Eagle Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
39.00
|
|
Average Rating
|
3.67
|
|
# Strong Buys
|
1
|
|
# Buys
|
0
|
|
# Holds
|
2
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
0.91
|
1.12
|
0.21
|
23.08%
|
|
2022-06-30
|
3.36
|
1.56
|
-1.80
|
-53.57%
|
|
2022-03-31
|
3.88
|
4.04
|
0.16
|
4.12%
|
|
2021-12-31
|
0.94
|
0.85
|
-0.09
|
-9.57%
|
|
2021-09-30
|
0.83
|
0.56
|
-0.27
|
-32.53%
|
|
2021-06-30
|
0.80
|
0.93
|
0.13
|
16.25%
|
|
2021-03-31
|
0.65
|
0.24
|
-0.41
|
-63.08%
|
|
2020-12-31
|
-0.17
|
0.96
|
1.13
|
664.71%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
6.72
|
|
2021-12-31
|
2.58
|
|
2020-12-31
|
3.54
|
|
2019-12-31
|
2.59
|
|
2018-12-31
|
3.86
|
|
2017-12-31
|
4.13
|
|
2016-12-31
|
4.99
|
|
2015-12-31
|
0.20
|
|
2014-12-31
|
-1.69
|